FFA
RANI icon

Farther Finance Advisors’s Rani Therapeutics RANI Stock Holding History

Farther Finance Advisors’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Hold
13,800
– – ﹤0.01% 4388
2026
Q1 		$11.1K Hold
13,800
– – ﹤0.01% 4033
2025
Q4 		$18.6K Buy
+13,800
New +$20.8K ﹤0.01% 3502

Other funds holding RANI

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Farther Finance Advisors's RANI Position: Q2 2026 in Review

Farther Finance Advisors held its Rani Therapeutics (RANI) position steady in Q2 2026 at 13,800 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4388.

Farther Finance Advisors first reported a position in RANI in Q4 2025 and has held it in 3 quarters since. The position peaked at $18.6K in Q4 2025. 5 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Farther Finance Advisors held 13,800 shares of Rani Therapeutics worth $10.5K as of Q2 2026.
  • Farther Finance Advisors left its Rani Therapeutics share count unchanged in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4388 holding.
  • Farther Finance Advisors first reported a position in Rani Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's Rani Therapeutics position peaked at $18.6K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.